How this Nasdaq-U.K.-listed Chinese biotech is revolutionizing cancer treatment
September 17, 2020 at 12:55 PM EDT
Chi-Med has been granted three U.S. Food and Drug Administration Fast Track Designations for its cancer drugs.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
